Search Results for “Case study - research” - Page 13

e-Newsletter June 2026

Our monthly e-Newsletter featuring the latest updates from Retina UK.

The cover of the Winter 2025 edition of Look Forward, featuring two of our volunteers cutting a special 50th anniversary cake

Look Forward – Winter 2025 – Issue 188

This is the final edition of Look Forward this year and what a year it has been! We’ve had some very positive feedback about our Conferences and the Big Give Christmas Challenge is back - a great opportunity to double your donation at no extra cost to you! We’ve included a handy ‘What’s on’ article which outlines some of our plans for 2026. We would like to take this opportunity to wish all of our readers a very Merry Christmas and a happy and fulfilling New Year.

Optogenetics

The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.

News

Major innovation award

Retina UK invites expressions of interest to their first major innovation grant call, which will result in an award of up to £1million over five years as a strategic and targeted investment to result in transformative impact for therapy for inherited retinal dystrophy.

Applying for research funding

We provide funding for innovative, high quality research projects investigating the causes and potential treatments for all forms of inherited retinal disease.

Retina UK Webinars: Prof Jacqueline van der Spuy, Prof Majlinda Lako and Elena Piotter - The Big Give - How your donations make a difference

Webinar: The Big Give: How your donations make a difference

Join us to find out how your donations make a direct different and fund research.

Could eye drops treat retinal disease in the future?

Researchers have developed PEDF-based eye drops that show promise in slowing retinal degeneration in mice with retinitis pigmentosa, potentially offering a non-invasive treatment option for preserving vision in the future.

Exciting developments for new treatment research

In recent years there has, understandably, been a lot of excitement around cutting-edge therapies that target the specific genetic faults underlying inherited sight loss.